FDA: Kratom an Opioid, Associated With 44 Deaths

The scientists also attacked the bad science the FDA used to claim deaths from kratom use, pointing out that "the fatalities that the FDA lists as having been associated with kratom include deaths with a wide variety of apparent causes in people suffering from various diseases and/or taking other substances that also likely contributed to their deaths".

The Food and Drug Administration declared this week that Kratom, a substance many opioid addicts have credited with helping them kick addictions, is a unsafe drug.

"We feel confident in calling compounds found in kratom, opioids", Food and Drug Administration commissioner Scott Gottlieb said in a statement.

US health authorities say an herbal supplement promoted as an alternative pain remedy contains the same chemicals found in opioids, the addictive family of drugs at the center of a national addiction crisis.

"Importantly, as commonly used in raw plant form, it does not appear to produce the highly addictive euphoria or lethal respiratory depressing effects of classical opioids", the group, including scientists from Johns Hopkins University, Columbia University and the University of Rochester, wrote. Advocates call it a safe way to deal with chronic pain and other conditions, and some researchers are exploring whether it helps people overcome addictions. While many of these cases could not be fully assessed because of limited information, one new report of death, in which the individual had no known historical or toxicologic evidence of opioid use besides kratom, was of particular concern.

As of February 6, 2018, FDA has reported 44 deaths involving the use of kratom; an increase from 36 reported in November 2017.

The FDA has submitted its review to the Drug Enforcement Administration, which is considering whether to place kratom in the same category of illegal drugs as heroin and LSD.

FDA officials have recommended kratom be categorized as a Schedule 1 drug, which would effectively mean that scientists would not be able to study its effects. FDA has stepped in, concerned over the product's lack of scientific evidence to support medical claims.

Gottlieb said his agency developed its computational model to identify the possibility of abuse of designer street drugs for which there is little pharmacological data.

Using that model, FDA scientists analysed the 25 most common compounds in kratom and concluded that all of them share the most structural similarities with opioid painkillers such as morphine derivatives. Further analysis confirmed that two of the most prevalent compounds in kratom are known to activate opioid receptors, and that kratom has a strong bind to mu opioid receptors, comparable to those of scheduled opioid drugs.

The American Kratom Association noted that a ban on kratom could result in up to $5 billion in financial losses by 10,000 kratom-related vendors.

Warning Over Kratom: What's the Real Impact for Pain Practitioners?

Related Articles

  • Alibaba Group (BABA) Stock Rating Reaffirmed by Jefferies Group

    Alibaba Group (BABA) Stock Rating Reaffirmed by Jefferies Group

    Pointstate Capital Lp increased its stake in Visa Inc (V) by 1016.54% based on its latest 2017Q3 regulatory filing with the SEC. Finally, Thomas White International Ltd. lifted its position in shares of Alibaba Group by 1.7% in the fourth quarter.
    Rey Mysterio vs. Jushin

    Rey Mysterio vs. Jushin "Thunder" Liger Signed for NJPW at "Strong Style Evolved"

    In their only other singles match at Starrcade 1996 , Liger defeated Mysterio with a Liger Bomb in 14:16. Mysterio is a big get for New Japan in its continued efforts to gain popularity in the United States.

    Welch & Forbes LLC Sells 7907 Shares of Danaher Co. (NYSE:DHR)

    Zacks Investment Research lowered Danaher from a "buy" rating to a "hold" rating in a research report on Tuesday, December 19th. It is negative, as 58 investors sold DHR shares while 367 reduced holdings. 78 funds opened positions while 352 raised stakes.
  • Essent Group Ltd (NYSE:ESNT) CFO Sells $10016.00 in Stock

    Essent Group Ltd (NYSE:ESNT) CFO Sells $10016.00 in Stock

    It increased, as 19 investors sold ESNT shares while 58 reduced holdings. 44 funds opened positions while 91 raised stakes. The stock of Microchip Technology Incorporated (NASDAQ:MCHP) has "Buy" rating given on Tuesday, August 9 by Citigroup.

    The Tahoe Resources (TAHO) Getting Somewhat Favorable Press Coverage, Analysis Finds

    Wall Street analysts are predicting that Tahoe Res Inc (NYSE:TAHO) will report earnings per share of $0 in their quarterly report. Macquarie lowered Tahoe Resources from an "outperform" rating to a "neutral" rating in a research report on Friday, July 7th.

    Motorcar Parts America Inc: Wellington Trust Co NA Makes Purchase

    Finally, TheStreet cut Motorcar Parts of America from a "b-" rating to a "c" rating in a research report on Tuesday, December 5th. Filings show 115 investors own Motorcar Parts America Inc . (NASDAQ:MPAA) has "Buy" rating given on Monday, March 14 by CL King.
  • Cheaper Or Expensive Than Peers? - STMicroelectronics NV (STM), Corning Incorporated (GLW)

    The firm has "Hold" rating by Stifel Nicolaus given on Thursday, April 13. ( NYSE:BKS ), 2 have Buy rating, 0 Sell and 4 Hold. Following the transaction, the insider now directly owns 72,039 shares in the company, valued at approximately $2,055,272.67.

    Worth Watching Stock Telefonaktiebolaget LM Ericsson (publ) (ERIC)

    Columbia Partners Llc Investment Management bought 10,519 shares as the company's stock rose 10.20% with the market. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.33 and a current ratio of 1.59.

    Assetmark Inc. Boosts Holdings in Altria Group Inc (MO)

    Pinnacle Wealth Management Advisory Group Llc sold 8,482 shares as the company's stock declined 2.84% while stock markets rallied. Colonial Advsr holds 55,540 shares. (NYSE:MO). 207,869 were reported by Cadence Capital Mngmt Ltd Limited Liability Company.
  • ImmunoGen (IMGN) Upgraded to Buy at BidaskClub

    It has outperformed by 34.56% the S&P500.The move comes after 6 months positive chart setup for the $2.50 billion company. Immunogen Inc (NASDAQ:IMGN) shares traded -2.77% down during most recent session to reach at the closing price of $8.76.

    Analyst Forecast Changes: HCA Healthcare, Inc. (HCA)

    Following the completion of the sale, the chief financial officer now owns 41,269 shares in the company, valued at $4,226,770.98. HCA Healthcare Inc has a 1-year low of $71.18 and a 1-year high of $106.84. (NYSE:HCA) shares were sold by RUTHERFORD BILL B.

    AvalonBay Communities (AVB) Issues FY18 Earnings Guidance

    AvalonBay Communities, Inc.'s Average Earnings Estimate for the current quarter is $2.21, according to consensus of 18 analysts. The other 1, though not evenly; between analysts who think you should buy NIC Inc. versus those who think you should sell it.